Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-20INVA3Insider Filing for Innoviva, Inc. (INVA)
This filing concerns Innoviva, Inc. (INVA) and an initial report of beneficial ownership by director Josephine Linden. The report indicates that Ms. Linden has no direct or indirect beneficial ownership of INVA securities as of May 18, 2026. The filing is an initial statement on Form 3, signifying no prior filings....
Small CapBiotechnology
2026-05-20KYTX3Power of Attorney for Gregory Martini, CFO of Kyverna Therapeutics
This SEC Form 3 filing includes a Power of Attorney document for Gregory S. Martini, Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX). The filing, dated May 20, 2026, documents Martini's appointment of Chihiro Saito and Samantha Eldredge as his attorneys-in-fact to execute and file Forms 3, 4, 5, and 144 on...
Small CapBiotechnology
2026-05-20Innoviva, Inc.3Insider Filing for Innoviva, Inc. (INVA)Duplicate
This filing concerns Innoviva, Inc. (INVA) and an initial report of beneficial ownership by director Josephine Linden. The report indicates that Ms. Linden has no direct or indirect beneficial ownership of INVA securities as of May 18, 2026. The filing is an initial statement on Form 3, signifying no prior filings....
Small CapBiotechnology
2026-05-20Kyverna Therapeutics, Inc.3Power of Attorney for Gregory Martini, CFO of Kyverna TherapeuticsDuplicate
This SEC Form 3 filing includes a Power of Attorney document for Gregory S. Martini, Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX). The filing, dated May 20, 2026, documents Martini's appointment of Chihiro Saito and Samantha Eldredge as his attorneys-in-fact to execute and file Forms 3, 4, 5, and 144 on...
Small CapBiotechnology